Protective effect of fucoidan from Fucus vesiculosus on liver fibrosis via the TGF-β1/Smad pathway-mediated inhibition of extracellular matrix and autophagy

Liver fibrosis is a dynamic reversible pathological process in the development of chronic liver disease to cirrhosis. However, the current treatments are not administered for a long term due to their various side effects. Autophagy is initiated to decompose damaged or excess organelles, which had been found to alter the progression of liver fibrosis. In this article, we hypothesized that fucoidan from Fucus vesiculosus may attenuate liver fibrosis in mice by inhibition of the extracellular matrix and autophagy in carbon tetrachloride- and bile duct ligation-induced animal models of liver fibrosis. The results were determined using enzyme-linked immunosorbent assay, quantitative real-time polymerase chain reaction, Western blotting, and immunohistochemical staining. Fucoidan from F. vesiculosus could inhibit the activation of hepatic stellate cells and the formation of extracellular matrix and autophagosomes, and its effect may be associated with the downregulation of transforming growth factor beta 1/Smads pathways. Fucoidan, as an autophagy and transforming growth factor beta 1 inhibitor, could be a promising potential therapeutic agent for liver fibrosis.

[1]  J. Ladero,et al.  Liver fibrosis. , 2018, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[2]  Xiaoming Fan,et al.  Ghrelin reduces liver impairment in a model of concanavalin A-induced acute hepatitis in mice , 2015, Drug design, development and therapy.

[3]  Fan Wang,et al.  Astaxanthin Pretreatment Attenuates Hepatic Ischemia Reperfusion-Induced Apoptosis and Autophagy via the ROS/MAPK Pathway in Mice , 2015, Marine drugs.

[4]  Jie Lu,et al.  Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis , 2015, Drug design, development and therapy.

[5]  Jinqiu Zhu,et al.  Advanced glycation end product (AGE)-induced hepatic stellate cell activation via autophagy contributes to hepatitis C-related fibrosis , 2015, Acta Diabetologica.

[6]  Ying-Jan Wang,et al.  Strategies to prevent and reverse liver fibrosis in humans and laboratory animals , 2015, Archives of Toxicology.

[7]  Ping Wang,et al.  Low‐molecular‐weight fibroblast growth factor 2 attenuates hepatic fibrosis by epigenetic down‐regulation of Delta‐like1 , 2015, Hepatology.

[8]  Hui-Chun Huang,et al.  The Beneficial Effects of P2X7 Antagonism in Rats with Bile Duct Ligation-induced Cirrhosis , 2015, PloS one.

[9]  Sanjay Kumar,et al.  Endoglin Regulation of Smad2 Function Mediates Beclin1 Expression and Endothelial Autophagy* , 2015, The Journal of Biological Chemistry.

[10]  Fan Wang,et al.  Protective Effects of Astaxanthin on ConA-Induced Autoimmune Hepatitis by the JNK/p-JNK Pathway-Mediated Inhibition of Autophagy and Apoptosis , 2015, PloS one.

[11]  I. Dixon,et al.  Autophagy is a regulator of TGF-β1-induced fibrogenesis in primary human atrial myofibroblasts , 2015, Cell Death and Disease.

[12]  Sabine Weiskirchen,et al.  Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis , 2015, Journal of visualized experiments : JoVE.

[13]  J. Sowers,et al.  Autophagy: a housekeeper in cardiorenal metabolic health and disease. , 2015, Biochimica et biophysica acta.

[14]  Jin Han,et al.  Fucoidan from Fucus vesiculosus Protects against Alcohol-Induced Liver Damage by Modulating Inflammatory Mediators in Mice and HepG2 Cells , 2015, Marine drugs.

[15]  Jie Lu,et al.  Combination therapy of ursodeoxycholic acid and budesonide for PBC–AIH overlap syndrome: a meta-analysis , 2015, Drug design, development and therapy.

[16]  J. Moreno-Cuevas,et al.  Protective mechanisms of medicinal plants targeting hepatic stellate cell activation and extracellular matrix deposition in liver fibrosis , 2014, Chinese Medicine.

[17]  Fan Wang,et al.  N-Acetylcysteine Attenuates Ischemia-Reperfusion-Induced Apoptosis and Autophagy in Mouse Liver via Regulation of the ROS/JNK/Bcl-2 Pathway , 2014, PloS one.

[18]  Miao Shen,et al.  Hydrogen sulfide, a potential novel drug, attenuates concanavalin A-induced hepatitis , 2014, Drug design, development and therapy.

[19]  Jing Yang,et al.  Chloroquine improved carbon tetrachloride-induced liver fibrosis through its inhibition of the activation of hepatic stellate cells: role of autophagy. , 2014, Biological & pharmaceutical bulletin.

[20]  W. Martinet,et al.  Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: a controversial issue. , 2014, World journal of gastroenterology.

[21]  Fan Wang,et al.  Hydrogen Sulfide Ameliorates Ischemia/Reperfusion-Induced Hepatitis by Inhibiting Apoptosis and Autophagy Pathways , 2014, Mediators of inflammation.

[22]  Fan Wang,et al.  Protective Effect of Astaxanthin on Liver Fibrosis through Modulation of TGF-β1 Expression and Autophagy , 2014, Mediators of inflammation.

[23]  Jianwei Wang,et al.  Hepatitis C virus core protein activates autophagy through EIF2AK3 and ATF6 UPR pathway-mediated MAP1LC3B and ATG12 expression , 2014, Autophagy.

[24]  J. Kwak.  Fucoidan as a Marine Anticancer Agent in Preclinical Development , 2014, Marine drugs.

[25]  Dan Wu,et al.  High Expression of IGFBP7 in Fibroblasts Induced by Colorectal Cancer Cells Is Co-Regulated by TGF-β and Wnt Signaling in a Smad2/3-Dvl2/3-Dependent Manner , 2014, PloS one.

[26]  Yasunori Sato,et al.  A possible involvement of endoplasmic reticulum stress in biliary epithelial autophagy and senescence in primary biliary cirrhosis , 2014, Journal of Gastroenterology.

[27]  Fan Wang,et al.  Ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy , 2013, Mediators of inflammation.

[28]  Maria Markaki,et al.  Crosstalk between apoptosis, necrosis and autophagy. , 2013, Biochimica et biophysica acta.

[29]  S. Friedman,et al.  Hepatic stellate cells and liver fibrosis. , 2013, Comprehensive Physiology.

[30]  J. Venkatesan,et al.  Brown seaweed fucoidan: biological activity and apoptosis, growth signaling mechanism in cancer. , 2013, International journal of biological macromolecules.

[31]  Man Liu,et al.  [Effect of autophagy inhibitor 3-methyladenine on proliferation and activation of hepatic stellate cells]. , 2013, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.

[32]  J. Debnath,et al.  Autophagy as a stress-response and quality-control mechanism: implications for cell injury and human disease. , 2013, Annual review of pathology.

[33]  S. Ryter,et al.  Autophagy in human health and disease. , 2013, The New England journal of medicine.

[34]  Hao Wang,et al.  Losartan Alleviates Renal Fibrosis by Down-Regulating HIF-1α and Up-Regulating MMP-9/TIMP-1 in Rats with 5/6 Nephrectomy , 2012, Renal failure.

[35]  S. Friedman,et al.  Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. , 2012, Gastroenterology.

[36]  L. V. van Grunsven,et al.  Autophagy: A new player in hepatic stellate cell activation , 2012, Autophagy.

[37]  You-Wen He,et al.  The crosstalk between autophagy and apoptosis: where does this lead? , 2012, Protein & Cell.

[38]  J. H. Fitton,et al.  Therapies from Fucoidan; Multifunctional Marine Polymers , 2011, Marine drugs.

[39]  Haibo Zhu,et al.  Fucoidan, a sulfated polysaccharide from brown algae, against myocardial ischemia-reperfusion injury in rats via regulating the inflammation response. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[40]  Craig E. Higgins,et al.  Redox-Induced Src Kinase and Caveolin-1 Signaling in TGF-β1-Initiated SMAD2/3 Activation and PAI-1 Expression , 2011, PloS one.

[41]  N. Osna,et al.  Involvement of autophagy in alcoholic liver injury and hepatitis C pathogenesis. , 2011, World journal of gastroenterology.

[42]  Soon-Sun Hong,et al.  Suppression by Fucoidan of Liver Fibrogenesis via the TGF-β/Smad Pathway in Protecting against Oxidative Stress , 2011, Bioscience, biotechnology, and biochemistry.

[43]  J. Clancy,et al.  Human Neutrophil Elastase-Mediated Cleavage Sites of MMP-9 and TIMP-1: Implications to Cystic Fibrosis Proteolytic Dysfunction , 2010, Molecular medicine.

[44]  V. Stonik,et al.  Fucoidan inhibits UVB-induced MMP-1 promoter expression and down regulation of type I procollagen synthesis in human skin fibroblasts. , 2009, European journal of dermatology : EJD.

[45]  S. Friedman.  Hepatic fibrosis -- overview. , 2008, Toxicology.

[46]  W. Kim,et al.  The global impact of hepatic fibrosis and end-stage liver disease. , 2008, Clinics in liver disease.

[47]  M. Kawase,et al.  Fucoidan partly prevents CCl4-induced liver fibrosis , 2008, European journal of pharmacology.

[48]  Christopher J. Parsons,et al.  Mechanisms of liver fibrosis. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[49]  R Weiskirchen,et al.  Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets , 2006, Journal of cellular and molecular medicine.

[50]  J. Armendáriz-Borunda,et al.  [Hepatic fibrosis: role of matrix metalloproteases and TGFbeta]. , 2005, Gaceta medica de Mexico.

[51]  S. Friedman,et al.  Activation of hepatic stellate cells--a key issue in liver fibrosis. , 2002, Frontiers in bioscience : a journal and virtual library.

[52]  P. Bioulac-Sage,et al.  [Mechanisms of hepatic fibrogenesis]. , 2002, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[53]  D. Brenner,et al.  The role of Smad3 in mediating mouse hepatic stellate cell activation , 2001, Hepatology.

[54]  J. Massagué,et al.  TGFbeta signaling in growth control, cancer, and heritable disorders. , 2000, Cell.

[55]  A. B. Sukhomlinov,et al.  [Liver cirrhosis]. , 1989, Fel'dsher i akusherka.

[56]  R. Perez-Tamayo,et al.  Collagenase in experimental carbon tetrachloride cirrhosis of the liver. , 1978, The American journal of pathology.

[57]  K. Porter,et al.  CYTOPLASMIC COMPONENTS IN HEPATIC CELL LYSOSOMES , 1962, The Journal of cell biology.